Energy Homeostasis and Body Weight before and after Cessation of Block and Replacement Therapy in Euthyroid Patients with Graves' Disease

Table 4

Plasma hormone concentrations at visit 1 and visit 2.

	Visit 1		Visit 2		𝑃	Reference range
	Median	Min.–max.	Median	Min.–max.
T4 (nmol/L)	95	60–170	90	70–130	0.362	70–150
FT4 (pmol/L)	13.7	10.0–19.3	14.0	10.5–21.3	0.676	10.0–23.0
T3 (nmol/L)	1.68	1.2–2.3	1.73	1.3–2.7	0.069	1.3–2.7
FT3 (pmol/L)	4.4	3.0–6.2	5.3	3.9–9.3	0.005	3.3–8.2
TSH (mU/L)	1.70	0.04–4.50	0.70	0.01–2.03	0.001	0.5–5.00
TBII (U/L)	1.3	0.5–8.9	1.1	0.5–7.6	0.007
Insulin (pmol/L)	30	15–131	32	15–136	0.695	34–172
Adrenalin (nmol/L)	0.08	0.05–0.48	0.09	0.05–0.51	0.872	0.00–0.55
Noradrenalin (nmol/L)	1.05	0.43–3.69	1.38	0.53–4.18	0.833	0.00–3.25